Zeltiq Aesthetics Revenue and Competitors

Location

$77.9M

Total Funding

Estimated Revenue & Valuation

  • Zeltiq Aesthetics's estimated annual revenue is currently $300M per year.(i)
  • Zeltiq Aesthetics's estimated revenue per employee is $2,654,867
  • Zeltiq Aesthetics's total funding is $77.9M.

Employee Data

  • Zeltiq Aesthetics has 113 Employees.(i)
  • Zeltiq Aesthetics grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Zeltiq Aesthetics?

Zeltiq™ (pronounced Zel 'teek) Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue. The Zeltiq approach utilizes a patented method called Cryolipolysis™ (the use of precisely controlled cooling to remove fat) that is designed to only kill fat cells and not harm the skin or other tissue.

keywords:N/A

$77.9M

Total Funding

113

Number of Employees

$300M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Zeltiq Aesthetics News

2022-04-20 - Why Linda Evangelista Was Left Disfigured By A Fat Freezing ...

So much so that in 2019, the Aesthetic Society ranked ... Zeltiq Aesthetics claims CoolSculpting lowers the number of fat cells in the...

2022-04-17 - Global Cryolipolysis Devices Market 2022 Trend Analysis and ...

ZELTIQ Aesthetics; Sinus Medical Deutschland; Zimmer Aesthetics; Solta Medical. Based on the geographical analysis, the Cryolipolysis Devices market is...

2022-04-06 - Aesthetic Laser Device Market Overall Study Report 2022 ...

Siemens AG, Ultrashape Ltd., Solta Medical, Inc., XIO Group, Zeltiq Aesthetics, Lutronic, Inc., Cutera Palomar Medical Technologies, Palomar...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.3M113-3%N/A
#2
$18.1M113102%N/A
#3
$16.5M11443%N/A
#4
$14.8M11448%N/A
#5
$28.9M118-10%N/A